Trust the (cell manufacturing) process: Turning Research into ATMP in Flemingsberg!
Are you a practicing scientist from academia and/or industry, or simply interested in advanced therapies? We at the Flemingsberg Science Foundation warmly welcome you to the most important ATMP event of the spring!
When? March 21st
Where? Svartsjön room, Novum building, Campus Flemingsberg
Hälsovägen 7, 141 57 Huddinge
Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, getting new Advanced Therapy Medicinal Products (ATMPs) from the research lab to the reality of the patient bedside, relies not only on a robust and scalable cell manufacturing process, but also on successful navigation of the regulatory environment and an engaged and supportive ATMP community.
As stakeholders with a shared vision of creating momentum in accelerating access to ATMPs in the Nordics, Flemingsberg Science Foundation, Karolinska ATMP-centrum and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in getting new ATMPs from concept to clinic. Join Nordic cell therapy experts and enthusiasts in uniting towards bringing more ATMP options to more patients, more efficiently.
Welcome!
Speakers:
Johnny Högberg
Matti Sallberg
Pontus Blomberg
Stephan Mielke
Gustaf Ahlén
Di Yu
Stina Wickström
Nikola Vojnovic
Register here
Partners
Karolinska Universitetssjukhuset
Karolinska Institutet
Miltenyi Biotec
Elicera Therapeutics AB
ATMP Sweden
Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science
Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund (ERDF) and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.
BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development
As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.
Sally Sow and Turn UP: Winners of the Flemingsberg Science Award IDEA 2024
The music world can be a challenging place, both for organizers trying to reach their audience and for music lovers searching for events that suit their taste. Sally Sow, the winner of the Flemingsberg Science Award IDEA 2024, has developed Turn Up, a platform that simplifies organizing, discovering, and participating in local music events. With a focus on inclusion and accessibility, she aims to create a music scene where everyone feels welcome.
KTH’s Technical Preparatory Year Moves to Flemingsberg – Student Numbers Expected to Double in Autumn 2025
In the autumn of 2025, KTH will relocate its Technical Preparatory Year spots from Södertälje to Flemingsberg, resulting in a significant increase in student numbers at Campus Flemingsberg. By nearly doubling available seats and introducing a new learning center model in collaboration with 3 municipalities, KTH aims to meet the growing demand for technical education in the region.
